The Cost Effectiveness of Sacubitril/Valsartan For The Treatment of Chronic Heart Failure With Reduced Ejection Fraction In Korea

This study aims to estimate the cost-effectiveness of sacubitril/Valsartan compared with Enalapril for the treatment of chronic heart failure patients with reduced ejection fraction (HFrEF) in Korea.

Source: Value in Health - October 1, 2017 Category: International Medicine & Public Health Authors: J Lee, S Ko Source Type: research